Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

GLUE stock price forecast

How will GLUE stock perform in 2026 and 2030?

This page primarily displays the projected price range for GLUE stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of GLUE, the development trends of Monte Rosa Therapeutics, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for GLUE. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Monte Rosa Therapeutics, Inc.'s financial performance and industry trends to provide short-term price predictions for GLUE stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year GLUE stock price forecast

Price target:
36.88 USD
+101.70%
Based on 1-year price forecasts from 74 analysts, the highest estimate is 54.8 USD, while the lowest estimate is 15.83 USD.

Analyst rating for GLUE

Based on ratings from 67 analysts over the past three months, the overall consensus is Hold.

Strong buy
20
Buy
19
Hold
5
Sell
10
Strong sell
13

FAQ

How has GLUE's EPS performed recently?

GLUE's EPS is projected to reach -- USD next quarter. Explore more Monte Rosa Therapeutics, Inc. financial data and stay up to date on the company's latest developments on the GLUE stock details page.

What is the revenue forecast for GLUE next quarter?

Monte Rosa Therapeutics, Inc.'s revenue is projected to reach 15.55M USD USD in the next quarter. You can view Monte Rosa Therapeutics, Inc.'s revenue and earnings on the GLUE stock details page.

What is the price target for GLUE?

Based on analyst estimates, the most likely target price for GLUE over the next 12 months is 36.88 USD, with a projected high of 54.80 USD and a projected low of 15.83 USD. To track whether this target is reached within the next year, you can view the GLUE stock price chart on the GLUE stock details page to check the current GLUE stock price, or follow the latest developments related to GLUE on the GLUE Stock News page.

What is the analyst rating for GLUE?

We collected ratings from 67 analysts who have evaluated GLUE stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of GLUE stock in 2030?

Based on price forecasts and analyses of Monte Rosa Therapeutics, Inc. from Wall Street analysts and major investment banks, GLUE is projected to trade between 36.57 USD and 182.85 USD in 2030.

GLUE stock chart

GLUE stock details

GLUE stock price change

On the last trading day, GLUE stock closed at 18.29 USD, with a price change of -1.16% for the day.

Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
NASDAQ/
GLUE stock price forecast